Condition: Neovascular Age-related Macular Degeneration · nAMD · Sponsor: Hoffmann-La Roche
This study will evaluate the efficacy, safety, and PK of ranibizumab 100 milligrams per milliliter (mg/mL) delivered every 24 weeks (Q24W) via the PDS implant compared with ranibizumab 0.5 milligrams (mg) delivered every 4 weeks (Q4W) as intravitreal (IVT) injection in Chinese participants with nAMD.
This description comes directly from the study's public registry record.
Reference Study ID Number: YR42983 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. and Canada) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Peking Union Medical College Hospital | Beijing, China | Recruiting |
| Beijing Hospital | Beijing, China | Withdrawn |
| Beijing Tongren Hospital | Beijing, China | Recruiting |
| West China Hospital, Sichuan University | Chengdu, China | Recruiting |
| Sichuan Provincial People's Hospital | Chengdu, China | Recruiting |
| Zhongshan Ophthalmic Center, Sun Yat-sen University | Guangzhou, China | Recruiting |
| The Second Affiliated Hospital of Harbin Medical University | Harbin, China | Recruiting |
| Qingdao Eye Hospital of Shandong First Medical University | Qingdao, China | Recruiting |
| Shanghai First People's Hospital | Shanghai, China | Recruiting |
| Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine | Shanghai, China | Withdrawn |
| The First Affiliated Hospital of China Medical University | Shenyang, China | Recruiting |
| Shanxi Eye Hospital | Taiyuan, China | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05562947